Prostatis Group’s Vanguard Mid-Cap ETF VO Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2024
Q3
Sell
-7,304
Closed -$442K 155
2024
Q2
$442K Sell
7,304
-304
-4% -$18.5K 0.16% 101
2024
Q1
$475K Sell
7,608
-268
-3% -$15.8K 0.18% 95
2023
Q4
$458K Buy
+7,876
New +$421K 0.19% 87
2023
Q1
Sell
-126,692
Closed -$6.46M 114
2022
Q4
$6.46M Buy
+126,692
New +$6.45M 3.94% 5
2021
Q4
Sell
-43,120
Closed -$2.55M 99
2021
Q3
$2.55M Buy
43,120
+4,656
+12% +$281K 1.53% 24
2021
Q2
$2.28M Buy
38,464
+28,280
+278% +$1.64M 1.56% 19
2021
Q1
$564K Sell
10,184
-96,460
-90% -$5.23M 0.44% 54
2020
Q4
$5.51M Buy
+106,644
New +$5.16M 4.62% 6

Other funds holding VO

Prostatis Group's VO Position: Q3 2024 in Review

Prostatis Group sold out of Vanguard Mid-Cap ETF (VO) in Q3 2024, closing a stake of 7,304 shares — an estimated $442K sold.

Prostatis Group first reported a position in VO in Q4 2020 and held it in 8 quarters. The position peaked at $6.46M in Q4 2022. 1,930 funds tracked by Wall St. Rank hold VO as of Q3 2024.

  • Prostatis Group reported no remaining Vanguard Mid-Cap ETF position as of Q3 2024 after selling out during the quarter.
  • Prostatis Group sold 7,304 Vanguard Mid-Cap ETF shares in Q3 2024, an estimated $442K.
  • Prostatis Group first reported a position in Vanguard Mid-Cap ETF in Q4 2020 and held it in 8 quarters.
  • Prostatis Group's Vanguard Mid-Cap ETF position peaked at $6.46M in Q4 2022.
  • 1,930 funds tracked by Wall St. Rank held Vanguard Mid-Cap ETF as of Q3 2024.

Based on Prostatis Group's 13F filing for Q3 2024, filed 21 Mar 2025.